These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts. Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
4. HCV, HIV, HBV and HDV infections in intravenous drug addicts. Coppola RC; Manconi PE; Piro R; Di Martino ML; Masia G Eur J Epidemiol; 1994 Jun; 10(3):279-83. PubMed ID: 7859838 [TBL] [Abstract][Full Text] [Related]
5. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Devi KhS; Singh NB; Singh HL; Singh YM J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Imani R; Karimi A; Rouzbahani R; Rouzbahani A East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086 [TBL] [Abstract][Full Text] [Related]
8. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712 [TBL] [Abstract][Full Text] [Related]
9. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
10. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B; Ann Ist Super Sanita; 2010; 46(1):59-65. PubMed ID: 20348620 [TBL] [Abstract][Full Text] [Related]
11. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia]. Kolovrat A; Jurisić I; Marić Z; Cvitković A Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM; J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479 [TBL] [Abstract][Full Text] [Related]
13. Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies. Pai NP; Dhurat R; Potter M; Behlim T; Landry G; Vadnais C; Rodrigues C; Joseph L; Shetty A BMJ Open; 2014 Dec; 4(12):e005040. PubMed ID: 25510882 [TBL] [Abstract][Full Text] [Related]
14. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. Al-Mughales JA J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital. Yang T; Chen Q; Li D; Wang T; Gou Y; Wei B; Tao C J Med Virol; 2018 Jan; 90(1):101-108. PubMed ID: 28792076 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection]. Cheng H Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. Broers B; Junet C; Bourquin M; Déglon JJ; Perrin L; Hirschel B AIDS; 1998 Oct; 12(15):2059-66. PubMed ID: 9814875 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients. Phuangchoei P; Chotiyaputta W; Chayakulkeeree M J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea. Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients. Dimitrakopoulos A; Takou A; Haida A; Molangeli S; Gialeraki A; Kordossis T J Infect; 2000 Mar; 40(2):127-31. PubMed ID: 10841086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]